ÐÓ
EN
  • Company
  • History
  • Development
  • Products
  • Contacts
Moscow office +7 (495) 646-28-68
Email info@obolensk.ru
feedback
ÐÓ
EN
  • Main Page
  • Company
  • History

History

alt
History Detailed chronology of our enterprise’s development
Company
CompanyAbout our company
and its achievements
History
HistoryDetailed chronology of our enterprise’s development
Development
DevelopmentWe will tell about the modern technologies used in our production
  • 1994
    «JSC «PE «Obolenskoe» is established at the base of State Research Center for Applied Microbiology and Biotechnology, Obolensk, the Serpukhov District, the Moscow Region.
    1994
  • 2010
    Reconstruction of the enterprise’s premises and launch of new production lines. As a result, a twofold increase in production volume.
    2010
  • 2013
    «JSC «PE «Obolenskoe» underwent two external audits confirming the compliance of its pharmaceuticals’ quality with the QMS (ISO) and the requirements of international GMP standards.
    2013
  • 2013
    The enterprise became a part of Alvansa Group since 2013; Gazprombank and the UFG Private Equity Investment Fund are its shareholders.
    2013
  • 2014
    Alvansa Group acquired Segmenta Pharmaceuticals, LLC, thereby expanding its product line.
    2014
  • 2015
    The company purchased Urdoksa® and Novobismol® brands from the pharmaceutical company Pharmproject, JSC (St. Petersburg).
    2014
  • 2015
    Start of investment program to modernize and expand the enterprise’s production facilities with the aim of increasing production volume of pharmaceutical products produced, as well as new products. Development of some sites of partner companies for the production of pharmaceuticals by «JSC «PE «Obolenskoe».
    2015
  • 2016
    The company began building new production facilities.
  • 2016
    According to DSM data for 2016, sales of Venarus® in packages have reached 61% in the last 5 years, bringing the product into second place in its category.
  • 2018
    December 28, 2018 - Sistema, a public Russian diversified holding company, acquired a stake in «JSC «PE «Obolenskoe». The package was acquired jointly with VTB Bank and OBL Pharm management from Alvansa Ltd, the main shareholders of which are Gazprombank and UFG Private Equity.
  • 2019
    On February 7, the grand opening of a new production site of «JSC «PE «Obolenskoe» took place.
© 2021 OBL Pharm
All rights reserved.
Made
by ZenDesign